
Ionis Pharmaceuticals
company0.0Global Dominance: 0.00%
Ionis Pharmaceuticals is a biopharmaceutical company known for its pioneering work in RNA-targeted drug discovery and development. The company specializes in designing and developing therapies for a variety of diseases, including genetic disorders, cancers, and cardiovascular diseases. In recent news, Ionis Pharmaceuticals was mentioned in the context of Novartis' recent setbacks in drug development, particularly regarding a collaboration on a cardiovascular drug that did not meet its efficacy targets in clinical trials.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Ionis Pharmaceuticals is mentioned as a partner company that would share the revenues from a potential blockbuster drug.
Pharma ist auch ein HochrisikogeschäftNeue Zürcher Zeitung·
Switzerland· 2026-09-17

